Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 21-30 of 45

Page
per page
  1. Sotrastaurin (AEB071)
    A8525 Sotrastaurin (AEB071)
    Target: PKC
    Summary: PKC inhibitor
      ≥21.9 mg/mL
  2. GNF 5
    A8604 GNF 5
    Target: Bcr-Abl
    Summary: Bcr-Abl inhibitor
  3. K02288
    B2286 K02288
    Target: ALK
    Summary: ALK inhibitor
      insoluble in H2O; ≥17.6 mg/mL
  4. DCC-2036 (Rebastinib)
    B1404 DCC-2036 (Rebastinib)
    Target: FLT3|Bcr-Abl|Tie-2|KDR
    Summary: Bcr-Abl inhibitor
      ≥27.7 mg/mL
  5. Chelerythrine Chloride
    A3306 Chelerythrine Chloride
    Target: PKC
    Summary: PKC antagonist
      insoluble in H2O; ≥19.2 mg/mL
  6. Hydroxyfasudil
    A3478 Hydroxyfasudil
    Target: ROCK|Rho-kinase
    Summary: Rho-kinase inhibitor and vasodilator
      Soluble in DMSO
  7. RKI-1447
    A3771 RKI-1447
    Target: ROCK
    Summary: Potent ROCK1/ROCK2 inhibitor
      insoluble in H2O; ≥16.3 mg/mL
  8. SB-505124 hydrochloride
    A3799 SB-505124 hydrochloride
    Target: ALK
    Summary: ALK5/ALK4/ALK7 inhibitor in TGF-β/activin signalling,selective
  9. SLx-2119
    A3825 SLx-2119
     1 Citation
    Target: ROCK
    Summary: Selective ROCK2 inhibitor
      ≥22.65 mg/mL
  10. Ro 31-8220
    B1287 Ro 31-8220
    Target: PKC
    Summary: pan-PKC inhibitor
      Soluble in DMSO

Items 21-30 of 45

Page
per page